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ABSTRACT
Introduction There are personal and societal benefits 
from caregiving; however, caregiving can jeopardise 
caregivers’ health. The Further Enabling Care at Home 
(FECH+) programme provides structured nurse support, 
through telephone outreach, to informal caregivers of older 
adults following discharge from acute hospital care to 
home. The trial aims to evaluate the efficacy of the FECH+ 
programme on caregivers’ health- related quality of life 
(HRQOL) after care recipients’ hospital discharge.
Methods and analysis A multisite, parallel- group, 
randomised controlled trial with blinded baseline and 
outcome assessment and intention- to- treat analysis, 
adhering to Consolidated Standards of Reporting Trials 
guidelines will be conducted. Participants (N=925 dyads) 
comprising informal home caregiver (18 years or older) 
and care recipient (70 years or older) will be recruited 
when the care recipient is discharged from hospital. 
Caregivers of patients discharged from wards in three 
hospitals in Australia (one in Western Australia and two 
in Queensland) are eligible for inclusion. Participants 
will be randomly assigned to one of the two groups. The 
intervention group receive the FECH+ programme, which 
provides structured support and problem- solving for the 
caregiver after the care recipient’s discharge, in addition 
to usual care. The control group receives usual care. 
The programme is delivered by a registered nurse and 
comprises six 30–45 min telephone support sessions over 
6 months. The primary outcome is caregivers’ HRQOL 
measured using the Assessment of Quality of Life—eight 
dimensions. Secondary outcomes include caregiver 
preparedness, strain and distress and use of healthcare 
services. Changes in HRQOL between groups will be 
compared using a mixed regression model that accounts 
for the correlation between repeated measurements.
Ethics and dissemination Participants will provide 
written informed consent. Ethics approvals have been 
obtained from Sir Charles Gairdner and Osborne Park 
Health Care Group, Curtin University, Griffith University, 
Gold Coast Health Service and government health data 
linkage services. Findings will be disseminated through 
presentations, peer- reviewed journals and conferences.
Trial registration number ACTRN12620000060943.
INTRODUCTION
In Australia, an estimated 2.65 million people 
provide informal care, 32% as primary care-
givers, of whom over 60% provide support 
for a spouse or parent.1 The proportion of 
older adults (aged 65 years and over) across 
the world is expected to double from 12% in 
2020 to 22% by 20502 and in Australia older 
people expect to continue to live at home, 
with less than 5% of older people living in 
Residential Aged Care (RAC) accommoda-
tion.1 Hence informal caregivers are critical 
in supporting older people to live at home for 
as long as possible.3
Strengths and limitations of this study
 ► The study uses a multicentre randomised design 
with blinded baseline and outcome assessment.
 ► Follow- up time points of 6 and 12 months allow ro-
bust evaluation of the effect of the Further Enabling 
Care at Home+ programme on caregivers’ outcomes 
as well as the use of health services.
 ► Evaluating secondary outcomes, including caregiver 
distress and preparedness to care will provide fur-
ther insight into the intervention effect.
 ► Participants cannot be blinded to receiving the 
intervention.
 ► The care recipients are older and therefore mortality 
and hospital readmission may affect the recruitment 
or retention of participants.
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Caregivers, however, report significant personal costs 
associated with care, including serious financial, social 
and health problems.4 5 Caregivers repeatedly report 
lower levels of well- being than the general population. 
Mental health risks are particularly severe, with caregivers 
reporting significantly higher levels of loneliness, anxiety, 
depression and stress than the general population.4–7 A 
systematic review found evidence of a negative impact of 
caregiving on both the mental and physical health of the 
informal caregiver.8 Rising levels of caregiver stress are 
known to predict premature admission of the care recip-
ient to RAC.9
There is limited evidence that providing supportive 
programmes, such as face- to- face training, telephone 
support or online digital programmes, can reduce the 
adverse consequences of caregiving for older adults.10–13 
In addition to problems faced by caregivers in providing 
ongoing care, there is limited evidence about how to 
effectively support caregivers of older adults when they 
are discharged from hospital, including what interven-
tions can sustain and improve caregivers’ health and 
well- being.14–16 Older adults discharged from hospital 
are at high risk of functional decline, unplanned hospital 
readmissions and injurious falls.17–19 This transition can 
be particularly problematic for older adults who receive 
care support and their caregivers. Lack of continuity 
of care and inadequate communication and discharge 
plans during this time of transition can increase care-
giver burden even further.20 21 A recent meta- analysis of 
23 trials found low quality evidence that informal care-
giver interventions provided after hospital discharge may 
reduce caregiver burden and anxiety in stroke popu-
lations. However, they did not change health- related 
quality of life (HRQOL), anxiety or health resource 
use.15 Over 90% of the included trials were conducted in 
stroke populations thereby providing limited generalis-
ability. Another systematic review of 21 trials found that 
telephone interventions providing support for caregivers 
may slightly reduce anxiety and improve preparedness 
to care, but did not significantly improve other care-
giver outcomes.16 None of the included trials in this 
review measured changes in HRQOL16 and both reviews 
recommended further high- quality trials in caregiver 
populations. Recent qualitative research conducted with 
caregivers of older adults discharged from hospital indi-
cated that negative impacts of caregiving at this time can 
stem from feelings of uncertainty exacerbated by gaps in 
formal support, the strain of balancing caregiving with 
other life demands and a sense of helplessness.22 There-
fore further trials that design and evaluate interventions 
to support caregivers when the older adult they care for is 
transitioning from hospital to home are required.
We conducted a randomised controlled trial (RCT) 
evaluating the Further Enabling Care at Home (FECH) 
programme, a telephone- based intervention deliv-
ered to caregivers when the older adult they cared 
for was discharged from hospital.11 Telephone inter-
ventions are part of a suite of expanding telehealth 
technologies that demonstrate early evidence for 
providing support for caregivers and families.23 A 
brief intervention of seven Cognitive Behavioural 
Therapy (CBT) 60 min telephone sessions for care-
givers of adults with dementia resulted in improved 
caregiver emotional well- being, decreased exhaustion 
and reduced depressive symptoms.24 Caregivers asked 
to rate their preferences for telehealth technologies 
rated telephone as the highest preferred form of 
technology compared with videoconferencing, Face-
book, email and other technologies and telephones 
have the advantage of being usable for those without 
access to suitable technology and internet.25 A review 
of telephone and computer- delivered interventions 
for caregivers of people living with dementia found 
that these intervention have potential to improve 
caregiver well- being, in particular those that incor-
porated various elements of psycho- education, peer 
support, skills training and health assessments but 
that further high quality trials were required.26 The 
FECH telephone programme provided support for 
caregivers in a timely and convenient manner in their 
own home. It was tailored to address the caregivers’ 
identified support needs by providing immediate 
information and resources.11 In contrast to previous 
studies providing caregiver support,15 16 the FECH 
programme delivered promising results when piloted 
with caregivers of older patients following hospital 
discharge. The programme significantly reduced care-
giver strain and distress and increased preparedness 
to care.11 Caregivers also reported high levels of satis-
faction with the programme.27 While the programme 
achieved a moderate effect size that was clinically 
significant,11 the FECH programme had some limita-
tions. Caregiver support was limited to receiving three 
telephone contacts over 3 weeks after discharge and 
did not take an approach that assisted caregivers to 
develop and implement problem- solving skills. The 
trial was conducted in a single hospital ward and 
141 dyads provided data at all time points. Since it is 
evident that caring frequently results in a significant 
negative impact across mental, physical, social and 
emotional health of caregivers,4 5 we seek to measure 
the impact of the intervention by using a HRQOL tool. 
These tools are patient- reported outcome measures 
and therefore capture the individuals own percep-
tion of their health and well- being in a broad sense 
including their quality of life.28 Therefore we aim to 
increase the duration and intensity of the programme 
(FECH+) and conduct a multicentre RCT to evaluate 
whether the FECH+ programme may improve care-
givers’ HRQOL. Secondary aims will assist to explore 
potential causal mechanisms (such as reduction in 
caregiver distress and improved caregiver self- efficacy) 
by which participation in the FECH+ programme in 
addition to usual discharge care may improve care-
giver HRQOL. Since the original FECH programme 
improved caregiving preparedness, we also seek to 
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examine if the FECH+ programme results in improve-
ments in care, and therefore in care recipients’ levels 
of independence and symptoms of distress.
Aims and hypotheses
The primary aims of the trial are to (i) evaluate the effi-
cacy of participation in the FECH+ programme in addi-
tion to usual discharge care on HRQOL of caregivers of 
older adults discharged home from hospital, compared 
with receiving usual discharge care alone: (ii) evaluate 
the cost- effectiveness of the intervention using the frame-
work of a within- trial, cost- utility analysis. The secondary 
aims are to evaluate the efficacy of participation in the 
FECH+ programme in addition to usual discharge care 
on: (i) caregiver preparedness to care, caregiver self- 
efficacy and levels of strain and distress; (ii) care recipient 
outcomes of symptoms of distress and level of indepen-
dence, compared with usual discharge care alone.
The primary hypothesis is that caregivers participating 
in the FECH+ programme in addition to receiving usual 
hospital discharge care (intervention group) when 
compared with caregivers receiving usual discharge care 
alone (control group), will report improved HRQOL. 
Secondary hypotheses are that the: (1) intervention 
group will report improved caregiving preparedness, 
decreased strain and distress and improved caregiver 
self- efficacy compared with the control group; and (2) 
care recipients in the intervention group will experience 
decreased symptom distress and improved independence 
compared with the control group.
A separate process evaluation will be conducted to 
explore how caregiving is impacted by participating in 
the FECH+ programme and identify aspects of imple-
mentation that particularly contribute to effectiveness. A 
subsequent trial- based economic evaluation will evaluate 
the cost- effectiveness of the intervention using the frame-
work of a within- trial, cost- utility analysis.
METHODS AND ANALYSIS
Design
The trial is a multicentre parallel two- group RCT with 1:1 
dyad allocation to the intervention (FECH+ programme 
in addition to usual care) group or the control (usual care 
alone) group. The study will adhere to the Consolidated 
Standards of Reporting Trials guidelines (see figure 1).29 
This protocol is reported in accordance with the Stan-
dard Protocol Items: Recommendations for Interven-
tional Trials 2013 statement (see online supplemental file 
1).30 The trial is registered through the Australian New 
Zealand Clinical Trials Registry.
Figure 1 Participant flow through the study. FECH+, Further Enabling Care at Home.
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Participants
Participants will be enrolled as dyads (caregiver and care 
recipient). To be eligible for the study caregivers must be: 
(a) aged 18 years or older; (b) providing unpaid support 
as a caregiver to a patient (care recipient) aged 70 years 
or older when this care recipient is discharged home from 
a ward included in the study; care recipients must be: 
(c) discharged home from a ward included in the study. 
Exclusion criteria are that care recipients are discharged 
to a setting other than home (such as to a nursing home 
or another hospital) or undertake a hospital in the home 
programme. Based on a definition of a caregiver used in 
an Australian study investigating the support of frail older 
people,31 caregivers are defined as family members or 
friends providing care and support to older people. The 
support must be regular (at least weekly) ongoing, home- 
based and can be physical and/or emotional care. In 
Australia unpaid care and support is provided by family 
and friends on a voluntary basis as compared with paid 
caregivers who provide personal and home care services 
through aged care organisations.
Setting
The trial will be conducted at three public hospitals in 
Australia. In Western Australia (WA), the site is Sir Charles 
Gairdner Hospital, a metropolitan tertiary hospital with 
approximately 600 beds. In Queensland (QLD), the two 
hospitals are Robina Hospital (approximately 400 beds) 
and Gold Coast University Hospital (approximately 600 
beds). Wards included in the trial admit medical patients, 
of whom large numbers are aged over 70 years.
Randomisation and blinding
The WA Health Translation Network’s Clinical Trials 
and Data Management Centre (CTDMC) will administer 
the randomisation process. The allocation list has been 
generated prior to trial commencement by the CTDMC 
using computer- generated random numbers and organ-
ised such that recruitment to the two study arms (WA and 
QLD) occurs at an approximately equal rate. The treat-
ment allocation list is stored as a password protected file 
at Curtin University and is only accessible to the trial’s 
CTDMC administrators. The research assistants (RAs) 
enter all baseline data directly into a secure online data-
base. Completion of baseline data entry automatically 
triggers the allocation of the dyad (caregiver and care 
recipient) to the next number in the sequence and trig-
gers an alert to the project manager, who contacts the 
FECH+ nurse if the dyad is allocated to the intervention 
group.
The investigators on the trial team are not involved 
in recruitment or data collection and all investigators, 
including the statistical team, are blinded to group allo-
cation until after analyses are completed. RAs who enrol 
patients and conduct baseline and outcome assessments 
are blinded to group allocation throughout the study. 
The project manager is the only team member to see the 
group allocation as she manages the trial procedure. The 
nurses who deliver the intervention know which partic-
ipants receive the intervention, but are not involved in 
baseline or outcome data collection. Hospital staff who 
organise discharge services remain blinded to partic-
ipants’ enrolment into the study. Participants are not 
specifically informed of their group allocation but cannot 
be blinded to the intervention they receive. Participants 
will be instructed at enrolment and during monthly 
phone calls not to divulge their allocation to research 
staff. RAs who conduct baseline and outcome assessments 
are based in the hospitals while the nurses who deliver the 
intervention are located at the universities, to maintain 
blinding of staff.
Intervention
Participants allocated to the intervention receive the 
FECH+ programme in addition to usual care. A summary 
of the FECH+ programme is presented in table 1 using 
the Template for Intervention Description and Replica-
tion checklist.32 The FECH+ programme is a telephone- 
based, post- hospital- discharge intervention delivered to 
the caregiver by one or more specially trained ‘FECH+’ 
nurses. These registered nurses have acute gerontolog-
ical nursing care experience, have substantial knowledge 
on how to navigate the home care system and receive 
training in the FECH+ intervention.
The original FECH programme11 has been expanded 
(FECH+) to encourage and build the caregiver’s use 
of problem- solving skills, through instruction and role 
modelling, that they can continue to use after the inter-
vention period. Problem- solving is a practical step- by- step 
approach typically involving identifying and defining the 
problem, understanding it, setting goals and generating 
solutions, implementing a course of action, and evalu-
ating its efficacy.33
Training
The FECH+ nurses undertake 3 days face- to- face training 
in a group setting. This includes how to assess the care-
giver’s understanding of discharge information, how 
to use the Caregiver Support Needs Assessment Tool 
(CSNAT)34 to facilitate the caregivers’ identifying and 
prioritising support needs, and how to assist the caregiver 
to undertake a problem- solving approach.33 The CSNAT 
has 14 items with Likert- type response options that rate 
needs for support in two domains: enabling the care-
giver to care for the care recipient at home and enabling 
support for the caregiver in their caring role.34 Training 
materials include the resources associated with the online 
CSNAT toolkit35 and an electronic manual that provides 
information for caregivers related to care provision for 
older people in Australia, as well as a manual tailored for 
each state that outlines the problem- solving approach.27 
It is envisaged that two to three nurses will be employed 
at each site. Regular meetings for nurses to consolidate 
training procedures and to assist to monitor fidelity of 
intervention delivery will be conducted by the project 
manager and trial leaders (A- MH, CB, SS and LG). The 
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project manager will also monitor data entry for interven-
tion delivery through the online database.
Usual care
All participants in both intervention and control 
groups will receive usual discharge care. Usual 
discharge care includes providing the care recipient 
and/or caregiver with a copy of the discharge letter, 
medications or prescriptions, outpatient appoint-
ments and home care programmes organised by the 
hospital team. Social work input for caregivers is not 
routine but may occur when prioritised by the ward 
social worker during admission.
Outcome measures
The primary outcome (primary aim i) is care-
givers’ HRQOL at 6 months after hospital discharge 
measured using the 35- item Assessment of Quality of 
Life—eight dimensions (AQoL- 8D).36 37 The AQoL- 8D 
captures psycho- social as well as physical health 
domains (Independent Living, Happiness, Mental 
Health, Coping, Relationships, Self- Worth, Pain, 
Senses) and can be administered by telephone. The 
focus on psychosocial domains makes this instrument 
appropriate for our study since the dominant factor 
affecting choice of a multi- attribute utility instrument 
is its ability to capture facets of health states relevant 
to the research question.38 It has established validity 
and reliability, and good psychometric properties 
which capture psycho- social as well as physical health 
domains.37 Australian norms have been established for 
the AQol- 8D.39
Secondary outcomes are chosen to understand 
possible causal mechanisms of the intervention effect. 
For example, improved preparedness to care and 
reduction of caregiver strain and distress may improve 
caregivers HRQOL. Better prepared caregivers may in 
turn more effectively manage care recipients’ symp-
toms and functional limitations. The Preparedness 
Table 1 Summary of the FECH+ programme (Template for Intervention Description and Replication checklist)
(1) Brief name Further Enabling Care at Home (FECH+) for informal caregivers of older adults discharged home from 
hospital.
(2) Why The FECH+ programme offers a problem- solving, caregiver- focused approach to improve outcomes for 
the caregiver and care recipient that is complementary to usual discharge care. It is designed to provide 
caregivers with timely health professional support and training to use the resources available in the 
community. It aims to develop problem- solving skills and address the caregiver’s identified needs.
(3) What—materials The caregiver completes the CSNAT34 with support provided by the FECH+ nurse. A standard operating 
procedures manual is used by the nurse delivering the intervention. Resources relevant for individual 
caregivers, such as contacts for organisations, are emailed or mailed to participants as required. 




The FECH+ nurse facilitates caregivers to (a) reflect on the current caregiving situation, (b) identify and 
prioritise new or ongoing support needs and (c) implement a problem- solving approach to address 
these support needs. Caregivers are guided to address three prioritised needs using problem- solving 
techniques and goal setting. The first phone call explores the caregiver’s understanding of discharge 
information. During subsequent phone calls caring responsibilities are discussed, using the CSNAT34 to 
identify problems. The programme aims to facilitate the development of caregivers’ problem- solving skills 
to continue without support from the FECH+ nurse after the intervention is completed. Each contact point 
provides an opportunity to reinforce the problem- solving skills learnt.
(5) Who provided Registered nurses experienced in gerontological nursing and who have received training in delivering the 
FECH+ programme.
(6) How The FECH+ programme is delivered via telephone to the caregiver after the care recipient is discharged 
from hospital.
(7) Where Delivered directly to the caregiver in their home.
(8) When and how 
much
Six telephone calls by the FECH+ nurse after the care recipient’s discharge from hospital. Call 1 during 
the first week after discharge (15 min); Call 2 at 2 weeks after discharge (approximately 45 min); Calls 3 to 
6 at 1, 2, 4 and 6 months, respectively, after discharge, (each approximately 30 min).
(9) Tailoring The intervention is tailored to the needs of each caregiver, using a problem- solving approach to identify, 
prioritise and address the top three support needs. Individual resources are provided to participants 
according to problems or needs identified.
(10) Modifications To be reported at study conclusion.
(11) Fidelity To be reported at study conclusion.
(12) Adherence To be reported at study conclusion.
CSNAT, Carer Support Needs Assessment Tool.
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for Caregiving Scale (PCS), Family Appraisal of 
Caregiving Questionnaire- Palliative Care (FACQ), 
Symptom Assessment Scale (SAS) and Barthel Activi-
ties of Daily Living Index (BADLI) assessment instru-
ments were previously evaluated in our pilot trial as 
being feasible to administer to caregivers over the tele-
phone.11 Secondary outcomes are:
1. Caregivers’ HRQOL at 12 months after hospital dis-
charge (primary aim i: secondary time point) mea-
sured using the 35- item AQoL- 8D.36 37
Other secondary outcomes evaluated at 6 and 12 
months after hospital discharge include:
2. Caregivers’ self- rated preparedness for caregiving (sec-
ondary aim i), measured using the PCS,40 which covers 
multiple domains of caregiving including prepared-
ness to provide physical, emotional and instrumental 
care along with managing the stress of caregiving. This 
8- item scale has five response options (0=not at all pre-
pared, 4=very well prepared) and is designed for use 
with caregivers of older adults receiving homecare/ex-
periencing care transitions. The construct validity for 
the PCS has been established in older adults.41 Testing 
in patients with life- threatening illness confirmed satis-
factory internal consistency, reliability and stability and 
unidimensionality.42
3. Caregivers’ self- efficacy (secondary aim i), measured 
with the 21- item Caregiver Inventory.43 Self- efficacy is 
built through a mastery of tasks and ability to persist 
and has been shown to improve caregiver well- being.7 
This questionnaire has four subscales confirmed by 
factor analysis: Cronbach’s alpha for the scale was 0.91 
in a sample of caregivers of patients for whom the main 
diagnoses were cancer, chronic obstructive pulmonary 
disease, stroke, chronic heart failure and dementia. 
Responses are provided using a 5- point Likert scale.
4. Caregivers’ strain and distress (secondary aim i)), mea-
sured by the corresponding subscales of the FACQ, for 
which good internal consistency, reliability and con-
struct validity are confirmed.44 Responses are provided 
using a 5- point Likert scale.
5. Care recipients’ level of independence (secondary aim 
ii), reported by caregivers using the BADLI, which has 
established reliability and validity.45
6. Care recipients’ symptoms (secondary aim ii), mea-
sured using the SAS.46 Seven symptoms are each 
scored from 0 (not at all) to 10 (worst possible). Scores 
can be totalled, and caregiver proxies can complete re-
sponses. Adequate internal consistency reliability and 
test–retest reliability and concurrent validity have been 
demonstrated in older populations.46 47
Demographic data collected for caregivers and care 
recipients at baseline are age, gender, country of birth, 
number of prescription medications taken by caregiver 
and care recipient’s length of stay in hospital. Infor-
mation about the type, duration and amount of care 
provided by the caregiver, types of services received by 
the caregiver/care recipient and caregiver/care recipient 
health (number, type of health conditions) will also be 
collected.
Procedure
The study procedure is summarised in table 2. Participant 
dyads will be enrolled in the trial by the RAs within 24 
hours of discharge from hospital. Baseline (time point 
1) assessment, including demographic data collection, is 
completed during the first week after hospital discharge. 
Questionnaires are administered by phone by the RAs. 
Data collection at time points 2, 3 and 4 will be prompted 
by the project manager sending an alert to the RAs 
through the database and completed by phone for both 
intervention and control groups. This strategy ensures 
that FECH+ programme completion occurs prior to time 
point 3 data collection and maintains the RAs blinding to 
group allocation.
Statistical analysis plan
Characteristics of the groups will be summarised using 
descriptive statistics (frequencies and percentages for 
categorical variables; means, SD, medians and ranges for 
variables measured on a continuous scale). Differences in 
Table 2 Overview of procedure
Time point Time after discharge Measurement tools administered
T1 (baseline) data collection 1–4 days AQoL- 8D*, CGI, PCS, FACQ, SAS, BADLI, demographic data
Intervention group only: FECH+ nurse contacts 1–4: 1 week, 2 weeks, 1 month, 2 months after discharge.
T2 data collection 3 months AQoL- 8D, PCS, FACQ, SAS, BADLI
Intervention group only: FECH+ nurse contacts 5–6: 4 months, 6 months after discharge.
T3 data collection 6 months AQoL- 8D, CGI, PCS, FACQ, SAS, BADLI, qualitative interview 
(subset)
T4 data collection 12 months AQoL- 8D, CGI, PCS, FACQ, SAS, BADLI, qualitative interview 
(subset)
*AQoL- 8D measures health- related quality of life36.
AQoL- 8D, Assessment of Quality of Life—eight dimensions; BADLI, Barthel Activities of Daily Living Index; CGI, Caregiver Inventory; FACQ, 
Family Appraisal of Caregiving Questionnaire- palliative care; FECH+, Further Enabling Care at Home; PCS, Preparedness for Caregiving 
Scale; SAS, Symptom Assessment Scale.
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demographic and baseline health status variables between 
groups at baseline will be compared using χ2, t- tests or 
non- parametric Wilcoxon two- sample tests as appro-
priate. Changes from baseline in the AQoL- 8D score for 
the caregiver will be calculated to each time point and 
tested for normality using the Shapiro- Wilk statistic; if 
not normally distributed, a Box–Cox transformation 
will be applied to the measure before further analysis. 
Comparison of the changes in AQoL- 8D scores between 
control and intervention groups will be performed using 
a mixed regression model with the caregiver group iden-
tified as a random effect. This model takes into account 
the correlation between repeated measurements on each 
individual. An interaction term between time and group 
will be introduced into the model to test whether rates of 
change in the outcome differ between groups. If differ-
ences between the groups are evident at baseline, these 
will be included in the model as covariates so that adjust-
ment can be made before examining differences between 
groups in outcomes.
In our preliminary work11 there was <20% missing data. 
Missing data will be managed using multiple imputation 
methods informed by a sensitivity analysis to manage 
this, creating 25 or more data sets.48 Two analyses will be 
performed, namely: an analysis using only the observed 
data, and second, after missing value substitution, where 
necessary. Data will be analysed using an intention- to- 
treat approach. Secondary outcomes will be analysed in 
a similar manner to the primary outcome. Statistical anal-
yses will be conducted using Stata V.16 software (Stata 
Statistical Software, College Station, Texas: StataCorp). 
All hypothesis tests will be two- sided and p values of <0.05 
considered statistically significant.
Sample size
The primary outcome is the change in total score on the 
AQoL- 8D36 for the caregiver at 6 months post- discharge. 
A very small effect size of 0.06 has been described as 
being of clinical importance.49 However, we antici-
pate a larger effect size, based on: (a) our assessment 
of changes in health, measured using a health- related 
quality of life questionnaire [short form survey -12 item 
(SF12)]50 during our preliminary study,11 in which we 
obtained a positive change in physical health (0.17) and 
mental health (0.22) from baseline until immediately 
post- intervention; (b) that the AQoL- 8D is a more appro-
priate outcome measure as psychosocial components of 
health are emphasised more; and (c) that we are now 
implementing an expanded intervention with longer 
follow- up. Therefore, we designed this study with 80% 
power to detect an effect size of 0.22. This would require 
648 caregiver dyads (324 in each of the control and inter-
vention groups), determined using the G*Power sample 
size calculator.51 We anticipate 30% attrition during 
the 12- month post- discharge period so our recruitment 
target to address the primary outcome variable is 925 
dyads. Based on preliminary work, this sample size will 
also allow 80% power to detect meaningful differences 
in the secondary outcomes for caregiver preparedness, 
strain and distress, and hospitalisation costs for patients.11
Process evaluation
A process evaluation will assist in understanding the 
mechanism of the trial results. The process evalua-
tion uses the framework recommended by the Medical 
Research Council for evaluating complex interven-
tions.52 Caregivers’ and nurses’ feedback on aspects 
of programme implementation will be evaluated. A 
purposive sample (estimated 25–40) of caregivers from 
WA and QLD who have completed participation in the 
FECH+ programme will be selected immediately after 
programme conclusion for inclusion in qualitative inter-
views. Sample selection will ensure maximum variation 
(eg, gender, age, relationship, caregiving duration), until 
data saturation.53 Qualitative, digital, audio- recorded and 
transcribed semi- structured telephone interviews (esti-
mated 10–20 min) will be scheduled at two time points 
(at the end of the intervention and 6 months later) to 
explore how the FECH+ programme has influenced care-
giving and caregiver experiences during and after the 
programme. FECH+ nurses will also be asked to record 
their reflections on each FECH+ programme contact. 
This includes identifying barriers to, or facilitators of, the 
effectiveness of the FECH+ programme.
Programme implementation will be examined by 
addressing fidelity, safety, adaptations, reach and dose.52 
Data to be collected by the FECH+ nurses as they deliver 
the intervention include: (a) adherence to or deviation 
from planned FECH+ processes including any safety 
concerns and how addressed; (b) information provided 
to caregivers and the extent to which caregivers engaged 
with resources provided; c) time taken to implement 
processes, including duration and frequency of sessions.
Qualitative data will be analysed using thematic anal-
ysis.53 Strategies to enhance the trustworthiness of findings 
will include verbatim transcriptions of audio- recorded 
interviews and an audit trail.53 Quantitative data will be 
presented using the framework of the process evaluation 
and where appropriate triangulated with qualitative data 
to assist in clarifying complex causal pathways.52
Economic analysis
The economic analysis plan will be published separately. 
Briefly, cost- effectiveness of the intervention (primary 
aim ii) will be measured using a within- trial cost- utility 
analysis. We shall evaluate the mean incremental cost and 
quality- adjusted life years (QALYs) according to the two 
randomised groups, taking an intention- to- treat perspec-
tive. A 12- month time horizon will be used, taking a health 
system perspective.
Data management
Data management will be overseen by a data management 
committee comprising a representative from the CTDMC, 
the WA and QLD state managers and trial leaders from WA 
(A- MH) and QLD (WM). The committee will undertake 
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regular monthly monitoring and auditing of data entry 
procedures and guide all data management. Data security 
is primarily addressed by the use of REDCap, an online 
application that provides for secure data entry, storage 
and transfer (https://www. project- redcap. org/). The 
CTDMC administers REDCap and all data are stored in 
WA. Administrative data (which include names and dates 
of birth) that are accessed via the database for merging 
with the health data will be locked down prior to creating 
a merged data set and are only accessible to a CTDMC 
administrator. De- identified data sets will be uploaded 
through the university’s encrypted system and stored on a 
password protected drive (at Curtin University). All data 
will be securely managed and stored at Curtin University 
as per National Health and Medical Research Council 
Australia guidelines, State data linkage services and 
Services Australia guidelines. Following the completion 
of the study analyses, a de- identified data set will be made 
available on reasonable request after ongoing secondary 
analyses are conducted and pending ethics approval from 
existing and requesting institutions and approval from all 
investigators.
Trial status
Recruitment commenced in August 2020 and is expected 
to be completed by approximately April 2022 with final 
follow- up occurring in April 2023. Primary data analyses 
will be completed, followed by the process evaluation. 
Final health data linkage will be undertaken in the 12 
months after final follow- up. Health economic analyses 
will then be completed.
Trial management
Any amendments required to the study will be agreed on 
by the trial management committee consisting of all chief 
investigators (A- MH, WM, RM, KH, NW, SS, CB and SA), 
and submitted to all ethics committees for approval prior 
to being commenced. The trial management committee 
will monitor the trial in accordance with the currently 
approved protocol, which includes submitting annual 
ethics reports detailing trial progress and any adverse 
events to all ethics committees. Each of the named inves-
tigators on the grant shall be eligible to have authorship.
Patient and public involvement
Two consumer advocates are members of the trial team. 
This study was developed with caregiver input from Carers 
WA and the WA Consumer and Community Health 
Research Network, prior to submitting the application 
for funding. The consumer input assisted to ensure the 
appropriateness of the intervention and study processes. 
This included assisting with wording of documents for the 
trial and aspects of procedure and intervention delivery. 
The two consumer advocates are ongoing members of 
the trial team and continue to inform and give feedback 
about the study procedure. Both consumer organisations 
will contribute to the dissemination of results and future 
presentations and translation projects.
Ethics and dissemination
The study has been approved by hospitals (the Sir Charles 
Gairdner Osborne Park Health Care Group, Gold Coast 
Health Care Group) and universities (Curtin and Grif-
fith) human research ethics committees. Approvals for 
linked health data for economic evaluation have been 
obtained from the Data Linkage Branches of WA Health, 
QLD Health and Services Australia (for national health 
administered data). All caregivers will provide written, 
informed consent to participate in the trial. Care recipi-
ents will also provide written, informed consent to partic-
ipate in the trial. Participant information and consent 
forms are provided as online supplementary files (see 
online supplemental file 2). Cognitive impairment may 
occur in a care recipient who forms part of the dyad. A 
waiver of consent has been approved in WA for these care 
recipients to be included in the study. If these care recip-
ients are encountered in QLD, we will seek consent from 
the appropriate substitute decision- maker.
To disseminate findings, Carers WA and Carers QLD, 
(two peak organisations who provide carer advocacy and 
support) will be asked to publicise the study completion 
and findings on their website. Our consumer advocates 
will provide advice and assistance to maximise engage-
ment strategies through established state and national 
consumer networks. Papers will be published in peer- 
reviewed journals, and abstracts submitted to relevant 
conferences. Practitioner and consumer forums will be 
held in participating hospitals and state health districts. 
Study participants will be provided with a summary of 
study findings on request.
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